Funding
Agency: Hellenic Foundation for Research and Innovation
Grant ID: HFRI 1289
Duration: 2018-2020
Type: Research Grant
Title: Targeting human Wnt1 via siRNA nanoparticles to boost dendritic cell vaccination against lung cancer neoantigens
Agency: Stavros Niarchos Foundation
Duration: 2017-2020
Type: Start-up grant
Agency: Hellenic Thoracic Society
Duration: 2015-2016
Type: Research Grant
Title: Harnessing mutant-tumor-antigen-specific T cells to treat non-small cell lung cancer.
Agency: Hellenic Thoracic Society
Duration: 2014-2015
Type: Research Grant
Title: Deciphering the link between chronic obstructive pulmonary disease and lung cancer: chronic inflammation-conditioned dendritic cells at the crossroads between cancer immune surveillance and escape.
Agency: Hellenic Thoracic Society
Duration: 2013-2014
Type: Research Grant
Title: The roles of caconical and non-canonical Wingless-type (Wnt) signalling pathways in non-small cell lung cancer escape from immunosurveillance mechanisms.
Agency: Hellenic Thoracic Society
Duration: 2011-2012
Type: Research Grant
Title: The role of pulmonary dendritic cells in the induction of defective adaptive immune responses against rhinovitus 16 (RV16) in the lungs of patients with Chronic Obstructive Pulmonary Disease (COPD).
